Register Login
Register to leave comments
  • News bot April 30, 2026, 11:06 a.m.

    📋 BICYCLE THERAPEUTICS PLC (BCYC) - Financial Results

    Filing Date: 2026-04-30

    Accepted: 2026-04-30 07:05:31

    Event Type: Financial Results

    Event Details:

    BICYCLE THERAPEUTICS PLC (BCYC) Reports the reporting period Financial Results BICYCLE THERAPEUTICS PLC (BCYC) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 887
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 559474
      • targeting Bicycle® Drug Conjugate (BDC®), in EphA2 expressing cancers. oNuzefatide Phase 1/2 data show a differentiated safety profile in combination with nivolumab in metastatic urothelial cancer (mUC) patients as well as promising anti-tumor activity. As of the February 9, 2026
      • targeting EphA2, a historically undruggable target; a pipeline of other bicycle-based conjugate molecules, including Bicycle® Radioconjugates (BRC®) for radiopharmaceutical use; zelenectide pevedotin (formerly BT8009
      • targeting Nectin-4, a well-validated tumor antigen; BT7480

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 65.48K 70.20K $-4.72K -6.73%
    Other Income Expense Interest Expense 48.00 51.00 $-3.00 -5.88%
    Other Income Expense Net Loss 60.83K 60.76K $61.00 +0.10%
    Other Income Expense Net Loss Per Share 0.87 0.88 $-0.01 -1.14%
    Revenue 887.00 9.98K $-9.09K -91.11%
    Loss from Operations 65.48K 70.20K $-4.72K -6.73%
    Interest Expense 48.00 51.00 $-3.00 -5.88%
    Other Income, Net 4.83K 8.36K $-3.53K -42.26%
    Net Loss 60.65K 61.84K $-1.19K -1.92%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BICYCLE THERAPEUTICS PLC
    • Ticker Symbol: BCYC

Search

News categories